| 1 |
Matias M, Santos AO, Silvestre S, Alves G. Fighting Epilepsy with Nanomedicines—Is This the Right Weapon? Pharmaceutics 2023;15:306. [DOI: 10.3390/pharmaceutics15020306] [Reference Citation Analysis]
|
| 2 |
Szaleniec J, Gibała A, Stalińska J, Oćwieja M, Żeliszewska P, Drukała J, Szaleniec M, Gosiewski T. Biocidal Activity of Tannic Acid-Prepared Silver Nanoparticles towards Pathogens Isolated from Patients with Exacerbations of Chronic Rhinosinusitis. Int J Mol Sci 2022;23. [PMID: 36499763 DOI: 10.3390/ijms232315411] [Reference Citation Analysis]
|
| 3 |
Said DE, Amer EI, Sheta E, Makled S, Diab HE, Arafa FM. Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection. Trop Med Infect Dis 2022;7. [PMID: 36548656 DOI: 10.3390/tropicalmed7120401] [Reference Citation Analysis]
|
| 4 |
Silva AC, Moreira JN, Lobo JMS. Editorial-Current Insights on Lipid-Based Nanosystems. Pharmaceuticals (Basel) 2022;15:1267. [PMID: 36297379 DOI: 10.3390/ph15101267] [Reference Citation Analysis]
|
| 5 |
Correia AC, Monteiro AR, Silva R, Moreira JN, Sousa Lobo JM, Silva AC. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders. Adv Drug Deliv Rev 2022;189:114485. [PMID: 35970274 DOI: 10.1016/j.addr.2022.114485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
de Barros C, Portugal I, Batain F, Portella D, Severino P, Cardoso J, Arcuri P, Chaud M, Alves T. Formulation, design and strategies for efficient nanotechnology-based nasal delivery systems. RPS Pharmacy and Pharmacology Reports 2022;1. [DOI: 10.1093/rpsppr/rqac003] [Reference Citation Analysis]
|
| 7 |
Chavda VP, Jogi G, Shah N, Athalye MN, Bamaniya N, K Vora L, Cláudia Paiva-santos A. Advanced particulate carrier-mediated technologies for nasal drug delivery. Journal of Drug Delivery Science and Technology 2022;74:103569. [DOI: 10.1016/j.jddst.2022.103569] [Reference Citation Analysis]
|
| 8 |
Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M, Figueiras A. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology. ACS Nano 2022. [PMID: 35729778 DOI: 10.1021/acsnano.2c00128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Pinto M, Silva V, Barreiro S, Silva R, Remião F, Borges F, Fernandes C. Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform. Ageing Res Rev 2022;79:101658. [PMID: 35660114 DOI: 10.1016/j.arr.2022.101658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Zhao Y, Li L, Zhou E, Wang J, Wang Y, Guo L, Zhang X. Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications. Pharmaceutical Fronts 2022;04:e43-e60. [DOI: 10.1055/s-0042-1751036] [Reference Citation Analysis]
|
| 11 |
Musumeci T, Di Benedetto G, Carbone C, Bonaccorso A, Amato G, Lo Faro MJ, Burgaletto C, Puglisi G, Bernardini R, Cantarella G. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease. Biomedicines 2022;10:985. [DOI: 10.3390/biomedicines10050985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Yan Z, Yang K, Tang X, Bi Y, Ding Y, Deng M, Xia D, Zhao Y, Chen T, Wang F. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis. Journal of Immunology Research 2022;2022:1-10. [DOI: 10.1155/2022/3851604] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 13 |
Szaleniec J, Gibała A, Stalińska J, Oćwieja M, Żeliszewska P, Drukała J, Szaleniec M, Gosiewski T. Pathogens in exacerbations of chronic rhinosinusitis differ in sensitivity to silver nanoparticles.. [DOI: 10.1101/2022.01.03.474872] [Reference Citation Analysis]
|
| 14 |
Trivedi S, Belgamwar V, Wadher K. Analytical profiling of Lentinan in hybrid nanostructures for intranasal Delivery: Method development and Validation. Results in Chemistry 2022;4:100471. [DOI: 10.1016/j.rechem.2022.100471] [Reference Citation Analysis]
|
| 15 |
Gugleva V, Ivanova N, Sotirova Y, Andonova V. Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies. Pharmaceuticals (Basel) 2021;14:837. [PMID: 34577536 DOI: 10.3390/ph14090837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
|
